HCID 178505530, 화합물 → HCID 178508807, 화합물

HRID 2283985노트

반응식

[Br:1][C:2]1[C:3]([NH2:29])=[N:4][CH:5]=[N:6][C:7]=1[N:8]1[CH2:13][CH2:12][CH:11]([C:14]2[NH:15][CH:16]=[C:17]([C:19]3[CH:24]=[CH:23][CH:22]=[C:21]([C:25]([F:28])([F:27])[F:26])[CH:20]=3)[N:18]=2)[CH2:10][CH2:9]1.[F:30]C1C=CC(C2N=C(C3CCNCC3)NC=2)=CC=1C(F)(F)F>>[Br:1][C:2]1[C:3]([NH2:29])=[N:4][CH:5]=[N:6][C:7]=1[N:8]1[CH2:13][CH2:12][CH:11]([C:14]2[NH:15][CH:16]=[C:17]([C:19]3[CH:24]=[CH:23][C:22]([F:30])=[C:21]([C:25]([F:28])([F:27])[F:26])[CH:20]=3)[N:18]=2)[CH2:10][CH2:9]1

참가 물질

반응물 2

HCID 178505530HCID 178505530, 화합물

HCID 178508806HCID 178508806, 화합물

생성물 1

HCID 178508807HCID 178508807, 화합물

실험 절차

The title compound was prepared in an analogous manner as 5-bromo-6-{4-[4-(3-trifluoromethyl-phenyl)-1H-imidazol-2-yl]-piperidin-1-yl}-pyrimidin-4-ylamine using 4-{4-[4-fluoro-3-(trifluoromethyl)phenyl]-1H-imidazol-2-yl}piperidine instead of 4-[4-(4-fluoro-3-trifluoromethyl-phenyl)-1-methyl-1h-imidazol-2-yl]-piperidine. LC-MS: (M+1=485, obsd.=485).

출처 및 근거

ORD 기록: ord-166568a29c964cb7bb4695b7cd485514
출처 데이터셋: uspto-grants-2015_09
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US09145392B2

반응 노트

불러오는 중…